Painreform Ltd (PRFX) Stock Analysis

Painreform Ltd (PRFX) is a publicly traded company in the HEALTHCARE sector. It trades at $2.02, carries a market capitalization of $2.61M. This page summarizes the public market data, fundamentals, and frequently asked questions for PRFX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $2.02
• Market Cap: $2.61M
• EPS: $-7.47
• 52-Week High: $11.85
• 52-Week Low: $1.28

Market Sentiment

Painreform Ltd currently has a Bullish sentiment score of 0.25.

About Painreform Ltd

PainReform Ltd. is a pioneering pharmaceutical company headquartered in Tel Aviv, Israel, specializing in the development of advanced therapies aimed at extending post-surgical pain relief. Through its proprietary drug delivery technology, the company addresses critical pain management challenges, enhancing the effectiveness and safety of analgesics. With a strong focus on transforming patient care in the postoperative environment, PainReform is well-positioned to lead innovations in the evol...

GNG Research Analysis

GNG Research scores Painreform Ltd (PRFX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PRFX.

Frequently Asked Questions

Does PRFX pay dividends?

Painreform Ltd (PRFX) does not currently pay a regular dividend.

What is PRFX's market cap?

Painreform Ltd (PRFX) has a market capitalization of $2.61M with a current stock price of $2.02.